| 21.42 Delayed Data As of Aug 23 |  -0.46 / -2.10%Today’s Change | 17.42 Today|||52-Week Range 23.03 | +16.67% Year-to-Date |
| Previous close | 21.88 |
| Today’s open | 21.71 |
| Day’s range | 21.39 - 22.03 |
| Volume | 1,516,622 |
| Average volume (3 months) | 1,353,710 |
| Market cap | $5.5B |
| Earnings growth (last year) | -7.00% |
| Earnings growth (this year) | +2.21% |
| Earnings growth (next 5 years) | +12.57% |
| Revenue growth (last year) | +7.57% |
| P/E ratio | 23.5 |
| Price/Sales | 2.37 |
| Price/Book | 3.09 |
| Today’s change | Today’s % change | |
|---|---|---|
| HZNPHorizon Therapeutics... | -0.49 | -1.77% |
| RDYDr.Reddy's Laborator... | -0.12 | -0.34% |
| RGENRepligen Corp | -1.80 | -1.94% |
| PRGOPerrigo Company PLC | -1.43 | -2.99% |
| Next reporting date | November 5, 2019 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $5.3B |
| Annual profit (last year) | $703.9M |
| Net profit margin | 13.30% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Joint Chief Executive Officer & Executive Director Raimon Grifols Roura |
Joint Chief Executive Officer & Executive Director Victor Grifols Deu |
Corporate headquarters Barcelona, Catalonia |
